Johnson & Johnson (JNJ) EPS (Basic) Growth (5y) (2014 - 2026)
Johnson & Johnson (JNJ) EPS (Basic) Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.66 Bn | 631.90 Bn | 17.26 Bn |
| 2 | AbbVie | 469.44 Bn | 462.87 Bn | 12.70 Bn |
| 3 | Merck | 377.01 Bn | 369.86 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.49 Bn | 294.80 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.82 Bn | 252.92 Bn | 12.86 Bn |
| 6 | Amgen | 236.92 Bn | 222.93 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.04 Bn | 179.87 Bn | 6.22 Bn |
| 8 | Pfizer | 160.40 Bn | 148.70 Bn | 10.94 Bn |
| 9 | Gsk | 106.00 Bn | 101.84 Bn | 8.24 Bn |
| 10 | Sanofi | 55.28 Bn | 47.90 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | -0.73% |
| Mar 29, 2026 | -1.59% |
| Dec 28, 2025 | 26.34% |
| Sep 28, 2025 | 9.64% |
| Jun 29, 2025 | 10.81% |
| Mar 30, 2025 | 15.73% |
| Dec 31, 2023 | -15.20% |
| Oct 1, 2023 | 42.48% |
| Jul 2, 2023 | -15.56% |
| Apr 2, 2023 | -36.94% |
| Jan 1, 2023 | 15.19% |
| Oct 2, 2022 | -47.43% |
| Apr 3, 2022 | -33.05% |
| Oct 3, 2021 | -2.29% |
| Jul 4, 2021 | 10.37% |
| Apr 4, 2021 | 7.81% |
| Jan 3, 2021 | -13.41% |
| Sep 27, 2020 | 2.16% |
| Jun 28, 2020 | -3.30% |
| Mar 29, 2020 | 7.23% |